Financhill
Back

Ultragenyx Pharmaceutical Vs. TransMedics Group Industry Stock Comparison

Sell
35

RARE
Ultragenyx Pharmaceutical

Last Price:
54.41
Seasonality Move:
7.55%
Buy
65

TMDX
TransMedics Group

Last Price:
159.11
Seasonality Move:
12.72%
Sell
35
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $54.43. The Score for RARE is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
65
TransMedics Group (TMDX) is a Buy

Is TransMedics Group a Buy, Sell or Hold?

  • The current TransMedics Group [TMDX] share price is $159.14. The Score for TMDX is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
  • TMDX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $54.43
    The current trend is moderately bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.

TMDX Stock Price Chart

What is TransMedics Group's stock price today?

  • The TransMedics Group share price today is $159.14
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TMDX is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.8 Buy
Relative Strength Index (14 RSI): 43.18 Sell
Chaikin Money Flow: -435004 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (55.76 - 58.26) Sell
Bollinger Bands (100): (40.14 - 54.08) Buy

TMDX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.65 Sell
Relative Strength Index (14 RSI): 53.07 Buy
Chaikin Money Flow: 1647554 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (144.71 - 167.33) Buy
Bollinger Bands (100): (136.45 - 160.09) Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.08 Sell
20-day SMA: 56.96 Sell
50-day SMA: 52.99 Buy
200-day SMA: 46.88 Buy
8-day EMA: 56.5 Sell
20-day EMA: 56.46 Sell
50-day EMA: 53.4 Buy
200-day EMA: 47.32 Buy

TMDX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 156.82 Buy
20-day SMA: 152.14 Buy
50-day SMA: 155.84 Buy
200-day SMA: 116.53 Buy
8-day EMA: 154.32 Buy
20-day EMA: 154.91 Buy
50-day EMA: 153.28 Buy
200-day EMA: 123.8 Buy

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.53 per share, an increase next quarter of $0.18 per share, an increase this year of $1.07 per share, and an increase next year of $1.02 per share.

TransMedics Group Earnings Growth & TMDX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.45 per share, an increase next quarter of $0.19 per share, an increase this year of $1.86 per share, and an increase next year of $0.61 per share.

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

TransMedics Group Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):